We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > tafenoquine

News List

60 Degrees announces positive results of cell culture testing of ARAKODA for Covid-19 pharmaceutical-business-review
July 17, 2020
60 Degrees Pharmaceuticals, LLC (60P) announced that initial testing in cell culture shows that ARAKODA (tafenoquine) is active against SARS-CoV-2 at clinically relevant concentrations.
GSK considers splitting up pharmatimes
July 24, 2018
GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.
GSK submits bold US application for tafenoquine, targeting malaria pharmaasia
December 07, 2017
Bold GSK attempt is for the first new medicine targeting P.vivax malaria in 60 years. Tafenoquine is not approved for use anywhere in the world.